Literature DB >> 15305079

Bilateral pallidotomy for severe dystonia in an 18-month-old child with glutaric aciduria.

Goran Rakocevic1, Kelly E Lyons, Steven B Wilkinson, John W Overman, Rajesh Pahwa.   

Abstract

Glutaric aciduria type 1 is an inborn error of metabolism due to deficiency of glutaryl-CoA dehydrogenase. This disorder mainly affects children. The majority of patients develop a dystonic-dyskinetic syndrome. The dystonia is painful and can cause significant disability. This report documents an 18-month-old child, the youngest reported, who underwent pallidotomy for disabling dystonia. The surgery improved dystonic symptoms, especially pain in this child with minor complications related to the procedure. Pallidotomy is a reasonable option for children with dystonic symptoms secondary to glutaric aciduria. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305079     DOI: 10.1159/000077405

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  9 in total

1.  Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Authors:  S Kölker; E Christensen; J V Leonard; C R Greenberg; A B Burlina; A P Burlina; M Dixon; M Duran; S I Goodman; D M Koeller; E Müller; E R Naughten; E Neumaier-Probst; J G Okun; M Kyllerman; R A Surtees; B Wilcken; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-01-03       Impact factor: 4.982

2.  Intraventricular Baclofen for Treatment of Severe Dystonia Associated with Glutaryl-CoA Dehydrogenase Deficiency (GA1): Report of Two Cases.

Authors:  Saadi Ghatan; Malgosia A Kokoszka; Anne M Ranney; Kevin A Strauss
Journal:  Mov Disord Clin Pract       Date:  2016-01-05

Review 3.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

4.  Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options.

Authors:  A P Burlina; G Zara; G F Hoffmann; J Zschocke; A B Burlina
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 5.  Maintenance treatment of glutaryl-CoA dehydrogenase deficiency.

Authors:  C Mühlhausen; G F Hoffmann; K A Strauss; S Kölker; J G Okun; C R Greenberg; E R Naughten; K Ullrich
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 6.  What happened to posteroventral pallidotomy for Parkinson's disease and dystonia?

Authors:  Robert E Gross
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 7.  Surgery for Dystonia and Tremor.

Authors:  Jason L Crowell; Binit B Shah
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

Review 8.  Diagnosis and management of glutaric aciduria type I--revised recommendations.

Authors:  Stefan Kölker; Ernst Christensen; James V Leonard; Cheryl R Greenberg; Avihu Boneh; Alberto B Burlina; Alessandro P Burlina; Marjorie Dixon; Marinus Duran; Angels García Cazorla; Stephen I Goodman; David M Koeller; Mårten Kyllerman; Chris Mühlhausen; Edith Müller; Jürgen G Okun; Bridget Wilcken; Georg F Hoffmann; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2011-03-23       Impact factor: 4.982

Review 9.  Bilateral Pallidotomy for Dystonia: A Systematic Review.

Authors:  Liesanne M Centen; D L Marinus Oterdoom; Marina A J Tijssen; Ivon Lesman-Leegte; Martje E van Egmond; J Marc C van Dijk
Journal:  Mov Disord       Date:  2020-11-20       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.